We are live on ! Find out more
DA

DCF Advisers Portfolio holdings

AUM $375M
1-Year Est. Return 72.65%
This Fund
S&P 500
This Quarter Est. Return
+13.18%
1 Year Est. Return
+72.65%
3 Year Est. Return
+156.29%
5 Year Est. Return
+218.72%
10 Year Est. Return
–
AUM
$247M
AUM Growth
+$20.1M
Cap. Flow
+$1.08M
Cap. Flow %
0.44%
Top 10 Hldgs %
56.55%
Holding
90
New
8
Increased
18
Reduced
14
Closed
17

Top Buys

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$2.55M
2
IMPL
Impel Pharmaceuticals Inc. Common Stock
IMPL
+$1.06M
3
INTC icon
Intel
INTC
+$1.02M
4
T icon
AT&T
T
+$804K
5
REGN icon
Regeneron Pharmaceuticals
REGN
+$738K

Top Sells

Rank Stock Value
1
VZ icon
Verizon
VZ
+$2.61M
2
BABA icon
Alibaba
BABA
+$2.15M
3
GDX icon
VanEck Gold Miners ETF
GDX
+$1.92M
4
AMD icon
Advanced Micro Devices
AMD
+$1.34M
5
PSFE icon
Paysafe
PSFE
+$853K

Sector Composition

Rank Sector Weight
1 Healthcare 39.97%
2 Technology 13.69%
3 Communication Services 7.37%
4 Financials 4.79%
5 Consumer Discretionary 3.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VOO icon
1
PUT
Vanguard S&P 500 ETF
VOO
$979B
$28.4M 11.51%
+65,000
New +$27.4M
ITCI
2
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$18.8M 7.62%
359,000
-20,000
-5% -$840K
MU icon
3
Micron Technology
MU
$930B
$16.5M 6.7%
177,500
– –
QQQ icon
4
PUT
Invesco QQQ Trust
QQQ
$453B
$13.9M 5.65%
+35,000
New +$13.5M
ABBV icon
5
AbbVie
ABBV
$443B
$13.4M 5.45%
99,318
+21,568
+28% +$2.55M
GOOG icon
6
Alphabet (Google) Class C
GOOG
$4.36T
$12.6M 5.1%
87,000
– –
REGN icon
7
Regeneron Pharmaceuticals
REGN
$78.5B
$10.9M 4.4%
17,200
+1,200
+8% +$738K
XNCR icon
8
Xencor
XNCR
$1.5B
$9.7M 3.93%
241,763
+11,763
+5% +$446K
ARGX icon
9
argenx
ARGX
$53.4B
$8.76M 3.55%
25,000
– –
BAC icon
10
Bank of America
BAC
$435B
$6.47M 2.62%
145,500
-4,500
-3% -$205K
INCY icon
11
Incyte
INCY
$24.2B
$5.14M 2.08%
70,000
– –
GM icon
12
General Motors
GM
$80.4B
$4.98M 2.02%
85,000
-5,000
-6% -$292K
AMD icon
13
Advanced Micro Devices
AMD
$776B
$4.32M 1.75%
30,000
-10,000
-25% -$1.34M
GLD icon
14
SPDR Gold Trust
GLD
$131B
$4.27M 1.73%
25,000
+2,500
+11% +$420K
TPB icon
15
Turning Point Brands
TPB
$1.45B
$4.23M 1.71%
111,926
+10,926
+11% +$443K
C icon
16
Citigroup
C
$222B
$4.11M 1.67%
68,000
+3,000
+5% +$199K
PFE icon
17
Pfizer
PFE
$143B
$3.84M 1.56%
65,000
– –
ORCL icon
18
Oracle
ORCL
$374B
$3.71M 1.5%
42,500
+2,500
+6% +$235K
GDX icon
19
VanEck Gold Miners ETF
GDX
$22.7B
$3.68M 1.49%
115,000
-60,000
-34% -$1.92M
F icon
20
Ford
F
$58.5B
$3.5M 1.42%
168,750
+36,250
+27% +$667K
IAU icon
21
iShares Gold Trust
IAU
$62.9B
$3.48M 1.41%
100,000
– –
LLY icon
22
Eli Lilly
LLY
$1.02T
$3.11M 1.26%
11,250
– –
ALNY icon
23
Alnylam Pharmaceuticals
ALNY
$27.5B
$3.05M 1.24%
18,000
+500
+3% +$92.9K
PRTA icon
24
Prothena Corp
PRTA
$425M
$2.96M 1.2%
60,000
– –
AMGN icon
25
Amgen
AMGN
$208B
$2.87M 1.16%
12,750
+1,500
+13% +$317K
1
2 3 4

Similar funds

JIC
JRM Investment Counsel Omaha, Nebraska $375M AUM 13.43% 1-Year Est. Return
CIM
CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return
AIM
Access Investment Management Atlanta, Georgia $376M AUM 17.2% 1-Year Est. Return
MWM
McMill Wealth Management Norfolk, Nebraska $376M AUM 14.46% 1-Year Est. Return
RCP
RIT Capital Partners London, United Kingdom $374M AUM 25.18% 1-Year Est. Return
HPM
Helix Partners Management New York $374M AUM 136.73% 1-Year Est. Return
CAG
Compass Advisory Group Melville, New York $374M AUM 14.59% 1-Year Est. Return
LWMNY
Landmark Wealth Management (New York) Melville, New York $373M AUM 12.01% 1-Year Est. Return

DCF Advisers's Q4 2021 Portfolio in Review

As of Q4 2021, DCF Advisers held 90 positions worth $247M, up 8.9% from $227M the previous quarter. Its ten largest holdings account for 57% of the portfolio.

DCF Advisers's Q4 2021 filing shows 8 new, 18 increased, 14 reduced and 17 closed positions. Its largest new stake was Intel: 20,000 shares worth $1.03M. The largest sale was Verizon, an estimated $2.61M.

By sector, the portfolio is most concentrated in Healthcare at 40% of assets, up from 38% a quarter earlier, followed by Technology and Communication Services.

  • DCF Advisers's largest Q4 2021 buy was Intel: 20,000 shares worth $1.03M.
  • DCF Advisers added most to AbbVie in Q4 2021, an estimated $2.55M increase.
  • DCF Advisers's biggest Q4 2021 reduction was Verizon, cutting an estimated $2.61M.
  • DCF Advisers fully exited Alibaba in Q4 2021, selling an estimated $2.15M.
  • DCF Advisers's ten largest holdings make up 57% of its $247M portfolio in Q4 2021.
  • DCF Advisers opened 8 new positions and closed 17 in Q4 2021.
  • DCF Advisers's portfolio value rose 8.9% quarter-over-quarter to $247M.

Based on DCF Advisers's 13F filing for Q4 2021, filed 10 Feb 2022.